title: Congenital rubella syndrome and rubella in Vellore, South India.
abstract: Rubella, a mild, vaccine-preventable disease, can manifest as congenital rubella syndrome (CRS), a devastating disease of the fetus. To emphasize the inadequacy of the existing rubella vaccination programme in India, we evaluated epidemiological evidence of rubella virus activity with data available from a tertiary-care centre. The proportion of suspected CRS cases that were laboratory confirmed increased from 4% in 2000 to 11% in 2008. During the same period, 329 clinically suspected postnatal rubella cases were tested of which 65 (20%) were laboratory confirmed. Of women (n=770) of childbearing age, 12·5% were susceptible to rubella.
authors.affiliation: Department of Clinical Virology, Christian Medical College, Dr Ida Scudder Road, Vellore, India.
authors.forename: S
authors.initials: S
authors.lastname: Chandy
authors.forename: A M
authors.initials: AM
authors.lastname: Abraham
authors.forename: A K
authors.initials: AK
authors.lastname: Jana
authors.forename: I
authors.initials: I
authors.lastname: Agarwal
authors.forename: A
authors.initials: A
authors.lastname: Kekre
authors.forename: G
authors.initials: G
authors.lastname: Korula
authors.forename: K
authors.initials: K
authors.lastname: Selvaraj
authors.forename: J P
authors.initials: JP
authors.lastname: Muliyil
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007194:India / Q000453:epidemiology; D007223:Infant; D008297:Male; D012409:Rubella / Q000453:epidemiology* / Q000517:prevention & control; D012410:Rubella Syndrome, Congenital / Q000453:epidemiology* / Q000517:prevention & control; D012411:Rubella Vaccine / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D012411:Rubella Vaccine